Assignee
ASTELLAS PHARMA INC
JP·318 granted patents·234 pending applications·1,757 citations·filing 1999–2025
Top patents by PatentIndex Score
552 records- 0195US7772407B2C-glycoside derivatives and salts thereofASTELLAS PHARMA INC·Filed 2007·Granted Aug 10, 2010·40 cites·20 claims
- 0295US7728120B2EML4-ALK fusion geneASTELLAS PHARMA INC·Filed 2007·Granted Jun 1, 2010·23 cites·1 claims
- 0394US10556906B2Quinazoline compoundASTELLAS PHARMA INC·Filed 2019·Granted Feb 11, 2020·29 cites·12 claims
- 0494US7605131B2EML4-ALK fusion geneASTELLAS PHARMA INC·Filed 2008·Granted Oct 20, 2009·30 cites·4 claims
- 0594US7396665B2Method of producing FR901228ASTELLAS PHARMA INC·Filed 2001·Granted Jul 8, 2008·39 cites·4 claims
- 0693US11938133B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2023·Granted Mar 26, 2024·2 cites·23 claims
- 0793US11707451B2Pharmaceutical composition for modified releaseASTELLAS PHARMA INC·Filed 2020·Granted Jul 25, 2023·3 cites·6 claims
- 0893US7608280B2Method of producing FR901228ASTELLAS PHARMA INC·Filed 2008·Granted Oct 27, 2009·16 cites·7 claims
- 0993US7084164B2Triazole derivativeASTELLAS PHARMA INC·Filed 2005·Granted Aug 1, 2006·40 cites·7 claims
- 1093US6958339B2Pyrazole derivativeASTELLAS PHARMA INC·Filed 2001·Granted Oct 25, 2005·54 cites·15 claims
- 1192US11944620B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2023·Granted Apr 2, 2024·1 cites·18 claims
- 1292US11938132B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2023·Granted Mar 26, 2024·1 cites·23 claims
- 1392US11938131B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2023·Granted Mar 26, 2024·1 cites·7 claims
- 1492US11938130B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2023·Granted Mar 26, 2024·1 cites·7 claims
- 1592US11839689B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2022·Granted Dec 12, 2023·2 cites·7 claims
- 1692US10842780B2Pharmaceutical composition for modified releaseASTELLAS PHARMA INC·Filed 2017·Granted Nov 24, 2020·6 cites·25 claims
- 1792US10786500B2Stable pharmaceutical composition for oral administrationASTELLAS PHARMA INC·Filed 2016·Granted Sep 29, 2020·7 cites·11 claims
- 1892US9487491B2Diamino heterocyclic carboxamide compoundASTELLAS PHARMA INC·Filed 2014·Granted Nov 8, 2016·28 cites·26 claims
- 1992US7879844B2Heterocyclic janus kinase 3 inhibitorsASTELLAS PHARMA INC·Filed 2006·Granted Feb 1, 2011·29 cites·21 claims
- 2092US7776897B2Triazole derivative or salt thereofASTELLAS PHARMA INC·Filed 2005·Granted Aug 17, 2010·43 cites·14 claims
- 2192US7678820B2Hetero compoundASTELLAS PHARMA INC·Filed 2008·Granted Mar 16, 2010·28 cites·12 claims
- 2292US7153524B2Method for improving adsorption of a drug from ethylene oxide derivativeASTELLAS PHARMA INC·Filed 2003·Granted Dec 26, 2006·53 cites·6 claims
- 2391US10517966B2Anti-human MUC1 antibody Fab fragmentASTELLAS PHARMA INC·Filed 2017·Granted Dec 31, 2019·5 cites·32 claims
- 2491US7964710B2EML4-ALK fusion geneASTELLAS PHARMA INC·Filed 2009·Granted Jun 21, 2011·7 cites·1 claims
- 2591US7919494B2Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compoundASTELLAS PHARMA INC·Filed 2009·Granted Apr 5, 2011·27 cites·13 claims
- 2691US7915261B2Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compoundASTELLAS PHARMA INC·Filed 2009·Granted Mar 29, 2011·28 cites·16 claims
- 2791US7611724B2Method of producing FR901228ASTELLAS PHARMA INC·Filed 2009·Granted Nov 3, 2009·13 cites·9 claims
- 2891US7449456B2Diaminopyrimidinecarboxamide derivativeASTELLAS PHARMA INC·Filed 2003·Granted Nov 11, 2008·58 cites·18 claims
- 2991US7285554B2Pyrazole derivativeASTELLAS PHARMA INC·Filed 2006·Granted Oct 23, 2007·19 cites·13 claims
- 3091US7255876B2Composition comprises sustained-release fine particles and manufacturing method thereofASTELLAS PHARMA INC·Filed 2002·Granted Aug 14, 2007·46 cites·20 claims
- 3191US7056883B2Therapeutic agent for soft tissue sarcomaASTELLAS PHARMA INC·Filed 2004·Granted Jun 6, 2006·53 cites·6 claims
- 3290US12077519B2Heteroaryl carboxamide compoundASTELLAS PHARMA INC·Filed 2023·Granted Sep 3, 2024·1 cites·14 claims
- 3390US11897954B2Anti-TSPAN8/anti-CD3 bispecific antibody and anti-TSPAN8 antibodyASTELLAS PHARMA INC·Filed 2021·Granted Feb 13, 2024·2 cites·20 claims
- 3490US7919495B2Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compoundASTELLAS PHARMA INC·Filed 2006·Granted Apr 5, 2011·23 cites·15 claims
- 3590US7465731B2HDAC inhibitorASTELLAS PHARMA INC·Filed 2005·Granted Dec 16, 2008·18 cites·18 claims
- 3689US12502357B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2024·Granted Dec 23, 2025·0 cites·1 claims
- 3789US10507251B2Anti-human MUC1 antibody fab fragmentASTELLAS PHARMA INC·Filed 2019·Granted Dec 17, 2019·3 cites·17 claims
- 3889US8716470B2Guanidine compoundASTELLAS PHARMA INC·Filed 2013·Granted May 6, 2014·12 cites·10 claims
- 3989US8012959B2Diaminopyrimidinecarboxamide derivativeASTELLAS PHARMA INC·Filed 2008·Granted Sep 6, 2011·20 cites·8 claims
- 4089US7056884B2Reduced FK228 and use thereofASTELLAS PHARMA INC·Filed 2001·Granted Jun 6, 2006·40 cites·6 claims
- 4188US10689393B2Tetrahydroisoquinoline derivativesASTELLAS PHARMA INC·Filed 2019·Granted Jun 23, 2020·3 cites·14 claims
- 4288US7968552B2Oxadiazolidinedione compoundASTELLAS PHARMA INC·Filed 2007·Granted Jun 28, 2011·9 cites·15 claims
- 4388US7951825B2Hetero compoundASTELLAS PHARMA INC·Filed 2010·Granted May 31, 2011·13 cites·3 claims
- 4488US2024117022A1Monoclonal antibodies against claudin-18 for treatment of cancerASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 4587US11679166B2Anti-human MUC1 antibody Fab fragmentASTELLAS PHARMA INC·Filed 2019·Granted Jun 20, 2023·2 cites·21 claims
- 4687US10888594B2Genetically engineered vaccinia virusesASTELLAS PHARMA INC·Filed 2017·Granted Jan 12, 2021·3 cites·25 claims
- 4787US10259821B2Tetrahydroisoquinoline derivativesASTELLAS PHARMA INC·Filed 2018·Granted Apr 16, 2019·3 cites·14 claims
- 4887US7709519B2Benzimidazolylidene propane-1,3 dione derivative or salt thereofASTELLAS PHARMA INC·Filed 2005·Granted May 4, 2010·13 cites·21 claims
- 4987US7342117B2α-form or β-form crystal of acetanilide derivativeASTELLAS PHARMA INC·Filed 2002·Granted Mar 11, 2008·28 cites·2 claims
- 5087US2024309108A1Antibodies against claudin 18.2 useful in cancer diagnosisASTELLAS PHARMA INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 552 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →